Article Text
PDF
Abstract
Women (N=21) who had had breast cancer and had been enrolled in a large genetic breast cancer epidemiological study were interviewed about their experience of participation in the study, their attitudes to the confidentiality of data, and the feedback of personal and general research results. Collection of family history information seemed more salient in indicating the genetic nature of the study than the enrolment information sheet. There were no concerns about confidentiality.
While participants would have welcomed general feedback about the results of the study and were critical that this had not been provided, the feedback of personal information proved complicated and, sometimes, difficult. It is suggested that individual feedback of genetic test information in epidemiological studies should be undertaken only when there are specific reasons.
- confidentiality
- feedback of research results
- consent procedures
- genetic risk information
Statistics from Altmetric.com
Footnotes
-
↵* Present address: Clinical Genetics Unit, Institute of Child Health, University of London, London, UK
Read the full text or download the PDF:
Other content recommended for you
- Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer
- Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
- BRCA1 andBRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
- Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
- Unique de novo mutation of BRCA2 in a woman with early onset breast cancer
- Breast cancer susceptibility variants alter risks in familial disease
- Retesting of women who are negative for a BRCA1 and BRCA2 mutation using a 20-gene panel
- Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries
- Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
- Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women